JPH03216198A - Anthracycline substance, preparation thereof and bacterium producing the same - Google Patents

Anthracycline substance, preparation thereof and bacterium producing the same

Info

Publication number
JPH03216198A
JPH03216198A JP4651190A JP4651190A JPH03216198A JP H03216198 A JPH03216198 A JP H03216198A JP 4651190 A JP4651190 A JP 4651190A JP 4651190 A JP4651190 A JP 4651190A JP H03216198 A JPH03216198 A JP H03216198A
Authority
JP
Japan
Prior art keywords
substance
culture
anthracycline
solution
ethyl acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4651190A
Other languages
Japanese (ja)
Inventor
Mikio Morioka
幹夫 森岡
Toshio Sasaki
敏雄 佐々木
Kenichi Suzuki
賢一 鈴木
Koji Nagai
浩二 永井
Yoji Yamaguchi
洋司 山口
Chieko Nohara
野原 智恵子
Tatsuhiro Tokunaga
徳永 達裕
Masashi Hiramoto
昌志 平本
Yukihiro Takebayashi
竹林 幸弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP4651190A priority Critical patent/JPH03216198A/en
Publication of JPH03216198A publication Critical patent/JPH03216198A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound of formula I (R<1> is H, OH; R<2> is H, lower alkyl; R<3> is H, lower alkanoyl). EXAMPLE:A compound of formula II. USE:An antitumor agent. PREPARATION:A microorganism belonging to the Nocardia strain such as Nocardia sp.-YL-01641P (FERM BP-2737) is cultured preferably at 25-32 deg.C at a pH of 6-8 for 24-120 hours.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は医薬殊に抗腫瘍薬として有用な化合物であるア
ンスラサイクリン系物質,発酵法による該物質の製造法
および該物質産生菌に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to an anthracycline substance which is a compound useful as a medicine, particularly an antitumor drug, a method for producing the substance by fermentation, and a bacterium producing the substance.

(発明が解決しようとする課題) 本発明者らは天然に存在する多くの微生物が生産する物
質について研究を行っていた所,ノカルディア属に属し
,アンスラサイクリン系物質を生産する能力を有する微
生物を培地に培養することによって,同培地中に強い抗
腫瘍作用を有する新規アンスラサイクリン系化合物が生
産されており,この物質を単離することにより本発明を
完成した。
(Problem to be Solved by the Invention) The present inventors were conducting research on substances produced by many naturally occurring microorganisms, and found that a microorganism belonging to the genus Nocardia and having the ability to produce anthracycline-based substances. By culturing this substance in a medium, a new anthracycline compound having a strong antitumor effect is produced in the same medium, and the present invention was completed by isolating this substance.

従来,微生物が生産する種々のアンスラサイクリン系化
合物には,例えばダウンマイシン,アドリアマイシン.
アクラシノマイシン等が知られており,これらの化合物
は臨床上非常に有効な薬剤でづhることもよく知られて
いる。しかしこれらの薬剤は投与の過程で必ずと言って
良いほど標的の腫瘍細胞がこれらの薬剤に対して耐性を
獲得する。本発明の新規なアンスラサイクリン系化合物
は後記のごとく,この様なアンスラサイクリン系化合物
に耐性を有する動物腫瘍細胞にも有効であることを発見
した。従って,本発明は優れた抗腫瘍作用を有するアン
スラサイクリン系物質を提供するものであり,また,本
発明は抗腫瘍物質を得るための新規な製造法を提供する
ものであり,更に本発明は上記アンスラサイクリy系物
質を産生ずる新菌株を提供するものである。
Conventionally, various anthracycline compounds produced by microorganisms include, for example, downmycin and adriamycin.
Aclacinomycin and the like are known, and it is well known that these compounds are clinically very effective drugs. However, during the course of administration of these drugs, target tumor cells almost always acquire resistance to these drugs. As described below, it has been discovered that the novel anthracycline compounds of the present invention are also effective against animal tumor cells that are resistant to such anthracycline compounds. Therefore, the present invention provides anthracycline substances having excellent antitumor effects, and also provides a novel manufacturing method for obtaining antitumor substances. The present invention provides a new bacterial strain that produces the above-mentioned anthracycline substances.

本発明で提供されるアンスラサイクリン系物質(I)は
下記平面化学構造式で表わされる。
The anthracycline substance (I) provided by the present invention is represented by the following planar chemical structural formula.

(式中, R+は水素原子又は水酸基をI R2は水素
原子又は低級アルキル基を,R3は水素原子又は低級ア
ルカノイル基を意味する。)本発明の化合物(I)の構
造上の特徴は,アンスラサイクリン系骨格の7位および
10位に糖鎖な有しており,殊に10位の糖鎖がアンス
ラサイクリン系抗生物質には従来見出されなかった4位
にジメチルアミノ基を有する糖鎖である点である。
(In the formula, R+ means a hydrogen atom or a hydroxyl group, R2 means a hydrogen atom or a lower alkyl group, and R3 means a hydrogen atom or a lower alkanoyl group.) The structural characteristics of the compound (I) of the present invention are that It has sugar chains at the 7th and 10th positions of the cyclin skeleton, and especially the sugar chain at the 10th position is a sugar chain with a dimethylamino group at the 4th position, which has not been previously found in anthracycline antibiotics. That's a certain point.

また,本発明の製造法は,ノカルディア属に属し,上記
アンスラサイクリン系物質を生産する能力を有する微生
物を培地に培養し,培養物中に該物質を生産させ,次い
で該物質を採取することからなるアンスラサイクリン系
物質の製造法である。
Furthermore, the production method of the present invention includes culturing a microorganism belonging to the genus Nocardia and having the ability to produce the above-mentioned anthracycline substance in a medium, producing the substance in the culture, and then collecting the substance. This is a method for producing anthracycline-based substances consisting of:

さらに,本発明の微生物は,上記アンスラサイクリン系
物質(I)を産生ずる能力を有するノカルディア属に属
する微生物である。以下,順次本発明の微生物,製造法
および該製造法で得られた本発明の化合物(I)につい
て詳述する。
Furthermore, the microorganism of the present invention belongs to the genus Nocardia and has the ability to produce the above-mentioned anthracycline substance (I). The microorganism of the present invention, the production method, and the compound (I) of the present invention obtained by the production method will be described in detail below.

本発明の新規な抗腫瘍作用を有する化合物を生産する菌
株はインドネシアで採取された土壌より分離された微生
物で,次のような菌学的性状を有する。
The strain producing the novel antitumor compound of the present invention is a microorganism isolated from soil collected in Indonesia, and has the following mycological properties.

1形態 各種有機及び無機培地で基生菌糸は良く発達,分岐し,
菌糸の幅はほぼ04μmであり,培養後期に菌糸どうし
の癒合が見られ,−!た培地によりわずかに菌糸の断裂
が観察される。気菌糸は長い直線状または曲線状で,不
規則に分岐し,比較的短い胞子柄を形成する。培養5〜
7週以降より胞子柄の先端部付近に5〜10個の胞子連
鎖を形成する。その先端部はゆるいコイル状2 である。一方,気菌糸主軸にも分断による長い胞子連鎖
が認められる事があり,その際菌糸は束状,ループ状を
呈し疑似胞子嚢様の構造が認められる事がある。胞子の
形状は円筒形,大きさは1.8〜12μm×05〜0.
8μmで,その表面は平滑である。胞子嚢胞子,菌核,
運動性のエレメント,輸生糸などの特殊な器官は観察さ
れない。
1. The basal hyphae are well developed and branched on various organic and inorganic media.
The width of the hyphae is approximately 04 μm, and fusion of hyphae is observed in the late stage of culture. Due to the medium used, slight rupture of hyphae is observed. Aerial hyphae are long straight or curved, irregularly branched, and form relatively short sporophytes. Culture 5~
From 7 weeks onwards, a chain of 5 to 10 spores is formed near the tip of the sporophyte. Its tip is loosely coiled 2 . On the other hand, long spore chains due to fragmentation may be observed in the main axis of aerial hyphae, and in this case, hyphae may take on bundle-like or loop-like shapes, and a pseudosporangium-like structure may be observed. The shape of the spore is cylindrical, and the size is 1.8-12μm x 05-0.
Its surface is smooth with a thickness of 8 μm. sporangia, sclerotia,
No motile elements or special organs such as sutures are observed.

各種寒天培地上の性状 各種寒天培地上の性状は,以下に示すとおりである。特
に記載しないかぎり,28℃で21日間培養し,常法に
従って観察したものである。
Properties on various agar media The properties on various agar media are as shown below. Unless otherwise specified, the cells were cultured at 28° C. for 21 days and observed according to conventional methods.

色調の記載については色の標準(日本色彩研究所)によ
った。
The description of color tone was based on the color standard (Japan Color Research Institute).

(注)G;生育程度 A;気菌糸の着生及びその色相 R;裏面の色相 S;可溶性色素 生埋的性質 1) 生育温度範囲 至適生育温度 20〜40℃ 27〜32℃ 2) ゼラチンの液化 単純ゼラチン(20゜C) グルコース・ペブトンゼラチン(28℃)陰性 陰性 3) 脱脂牛乳の凝固 脱脂牛乳のペプトン化 陽性 陽性 4) 硝酸還元作用 陽 性 5) スターチの加水分解作用 陰 性 6) メラニン様色素の生成 トリブトン・イーストエキス液体培地 チロシン寒天培地 ペブトン・イースト・鉄寒天培地 陰性 陰性 陰性 (注) 生育温度は各温度( 5, 10, 15, 20, 
25,28, 30, 37, 40. 45. 50
’C)で,7−21日までの観察結果を,ミルクに対す
る作用は37℃で3−21日までの観察結果を,それ以
外は,特に指摘のないかぎり28℃で2週間後の観察結
果を夫々示す。
(Note) G: Growth degree A; Aerial mycelial epiphytia and its hue R; Hue S on the back side; Soluble pigment bio-embedding properties 1) Growth temperature range Optimum growth temperature 20-40℃ 27-32℃ 2) Gelatin Liquefied simple gelatin (20°C) Glucose-pebutone gelatin (28°C) Negative 3) Coagulation of skimmed milk Positive peptonization of skimmed milk 4) Positive nitrate reducing action 5) Negative starch hydrolysis action 6) Melanin Formation of similar pigment Tributone yeast extract Liquid medium Tyrosine agar medium Pembone yeast iron agar medium Negative Negative (Note) Growth temperature is at each temperature (5, 10, 15, 20,
25, 28, 30, 37, 40. 45. 50
In 'C), the observation results from days 7 to 21 are shown, and the effects on milk are the results from days 3 to 21 at 37°C.Other than that, unless otherwise specified, the results are observed after 2 weeks at 28°C. are shown respectively.

4 炭素源の資化性(プリド・・ム・ゴドリーフ寒天培地,
28゜C培養) L−アラビノース ー マンノース D−キンロース  ー メリビオース D−グルコース  + ラクトース D−フラクトース  + D−ガラクトースシュクロー
ス   + マルトース イノシトール   + サリンン ラムノース     ー  トレハロースラフィノース
    ー グリセリン D−マンニトール + デキストリン スターチ     + キサンチン + + + (注)+:生育する   十一:生育が疑わしい:生育
しない 5 菌体成分の化学分析 LECHVALIERらの方法( LECHVALIE
R, MP. et al ;PP 277−238 
in DIETZ, A. et ed.+ Acti
nomyceteTaxonomy, SIM Spe
cial pub1icationA6+1980)に
従い本菌株の酸加水分解物および細胞壁成分の分析を行
った結果,表4の様に細胞壁タイプrV−Aであった。
4 Assimilation of carbon sources (Pridm Godleif agar medium,
28°C culture) L-arabinose - Mannose D-Kynlose - Melibiose D-Glucose + Lactose D-Fructose + D-Galactose Sucrose + Maltose inositol + Sarin Rhamnose - Trehalose Raffinose - Glycerin D-Mannitol + Dextrin starch + Xanthine + + + (Note) +: Grows 11: Growth is doubtful: No growth 5 Chemical analysis of bacterial cell components LECHVALIER et al.'s method (LECHVALIE
R, M.P. et al; PP 277-238
in DIETZ, A. et ed. +Acti
nomyceteTaxonomy, SIM Spe
cial publication A6+1980), the acid hydrolyzate and cell wall components of this strain were analyzed, and as shown in Table 4, the cell wall type was rV-A.

表4 全菌体還元糖 アラビノース, ガラクトース 主たるメナキノン種 MK−8 ミコール酸の存在  陽性 GC含量    66% 上記諸性状を要約すると, YL−01641P株は気
菌糸上に生じた短い胞子柄上に胞子の連鎖を作る。気菌
糸主軸の一部に培養後期に分断による胞子連鎖が認めら
れる。また,気菌糸の一部が束状を呈し,コイル状の構
造を形成する。疑似胞子嚢様の構造も観察される。基生
菌糸にも培養後期に断裂が生じることがある。細胞壁タ
イプはTV−Aで,主メナキノンはMK−8(H4,H
2)である。
Table 4 Total bacterial body reducing sugars arabinose and galactose Main menaquinone species MK-8 Presence of mycolic acid Positive GC content 66% To summarize the above properties, strain YL-01641P has spores on short sporophytes produced on aerial mycelia. Make a chain. Spore chains due to fragmentation are observed in a part of the main axis of aerial hyphae in the late stage of culture. In addition, some of the aerial hyphae are bundle-like, forming a coil-like structure. Pseudosporangium-like structures are also observed. Fractures may also occur in the basal hyphae during the late stage of cultivation. The cell wall type is TV-A, and the main menaquinone is MK-8 (H4, H
2).

以上の性質を有する菌種を各種の文献等により検索する
と,本菌株はいわゆるSporoactinomyce
s(胞子連鎖を形成する放線菌属)の範lに入る。
When searching various literature for bacterial species with the above properties, this strain was found to be the so-called Sporoactinomycetes.
It falls into the category of Actinobacteria s (genus Streptomyces that forms spore chains).

これらのうち表4の如き化学分類結果と形態的特性に合
致する既知菌属としては, Nocardia属が挙げ
られる。従来, Nocardia属は,培養初期の形
態や気菌糸の着生の有無などによって3型に分けられて
I+′た( Bergey’s manual of 
detarminative bacte−rio1o
gy,第8版(1974))が,特に■および■型にに
属する菌の多くがRhodococcusに移され全く
新しい観点からの分類基準が求められている。又Ber
gey’s manual of Systemati
c Bacteriology  (第2巻,1986
年)には9種のNocardiaが記載されているがY
L−01641 P株はそれらのいずれとも一致しなか
った。
Among these, the genus Nocardia is a known bacterial genus that matches the chemical classification results and morphological characteristics shown in Table 4. Traditionally, the genus Nocardia was divided into three types depending on the morphology at the initial stage of culture and the presence or absence of aerial hyphae (I+') (Bergey's manual of
determinative bacte-rio1o
gy, 8th edition (1974)), but in particular, many of the bacteria belonging to the ■ and ■ types have been transferred to Rhodococcus, and classification standards are being sought from a completely new perspective. Also Ber
gey's manual of Systemati
c Bacteriology (Volume 2, 1986
Nine species of Nocardia were described in
The L-01641 P strain did not match any of them.

この様な観点から本菌株をNocardia属に属する
一新菌種と判断し,ノカルディア エス・ピー(Noc
ardia sp.)YL  O1641Pと命名した
From this point of view, we judged this strain to be a new bacterial species belonging to the genus Nocardia, and identified it as Nocardia S.P.
ardia sp. ) YL O1641P.

本菌株は,工業技術院微生物工業技術研究所に微工研条
寄第2737号として寄託されている。
This bacterial strain has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology as FAIKEN Article No. 2737.

本発明のアノスラサイクリン系物質の製造法を実施する
に当たり,該物質の生産菌株ノカルディア エス・ピー
YL−01641P株を栄養源含有培地に接種して好気
的に発育させることにより本発明のアンスラサイクリン
物質を含む培養物が得られる。栄養物としては放線菌の
栄養源として公知のものが使用できる。たとえば市販さ
れているペプトン,肉エキス,コーン・スチープリカー
,綿実粉,落花生粉,大豆粉,酵母エキス,  NZ−
アミン,カゼインの氷解物,魚粉,硝酸ソーダー,硝酸
アンモニウム等の窒素源,市販されているグリセリン,
H#澱粉フ グルコース,マルトース,糖密等の炭水化
物あるいは脂肪等の炭素源および食塩,リン酸塩,炭酸
カルシウム,硫酸マグネシウム等の無機塩を使用できる
。これらのもの以外でも,該生産菌が利用し,本発明の
アンスラサイクリン系物質の生産に役立つものであれば
いずれでも使用することができる。
In carrying out the method for producing anosthracycline-based substances of the present invention, the production strain of the substance, Nocardia SP strain YL-01641P, is inoculated into a nutrient-containing medium and grown aerobically. A culture containing anthracycline material is obtained. As nutrients, those known as nutritional sources for actinomycetes can be used. For example, commercially available peptone, meat extract, corn steep liquor, cottonseed flour, peanut flour, soybean flour, yeast extract, NZ-
Nitrogen sources such as amines, melted casein, fishmeal, sodium nitrate, ammonium nitrate, commercially available glycerin,
H# starch carbohydrates such as glucose, maltose, and molasses or carbon sources such as fats and inorganic salts such as common salt, phosphate, calcium carbonate, and magnesium sulfate can be used. In addition to these substances, any substance that can be utilized by the producing bacteria and useful for producing the anthracycline substance of the present invention can be used.

培養法としては,一般の抗生物質の生産方法と同様に行
えばよく,その培養方法は固体培養でも液体培養でもよ
い。液体培養の場合は静置培養,攪拌培養,振盪培養,
通気培養などのいずれを実施してもよいが,特に通気攪
拌培養が好ましい。また,培養温度は生産菌が発育し,
本発明の物質を生産する温度,すなわち15℃〜40°
Cの範囲で適宜変更できるがおよそ25°C〜32℃の
範囲が好まし《,培地のpHは約4〜9の範囲で適宜変
更できるがpH6〜8が好ましい。培養時間は種々条件
によって異なり,lo時間〜168時間であるが,通常
24時間〜120時間程度で培養物中に蓄積される目的
物質が最高力価に達する。
The culturing method may be carried out in the same manner as a general antibiotic production method, and the culturing method may be solid culture or liquid culture. For liquid culture, static culture, agitation culture, shaking culture,
Although any method such as aerated culture may be used, aerated agitation culture is particularly preferred. In addition, the culture temperature allows the production bacteria to grow.
The temperature for producing the substance of the invention, i.e. 15°C to 40°C
The pH of the medium can be changed as appropriate within the range of approximately 25°C to 32°C, but is preferably within the range of about 4 to 9, but preferably 6 to 8. The culture time varies depending on various conditions and ranges from lo time to 168 hours, but the target substance accumulated in the culture usually reaches its maximum titer in about 24 hours to 120 hours.

培養物から目的とする化合物を採取するには微生物の生
産する代謝物の培養物から通常用いられる抽出,分離,
精製の手段が適宜利用される。培賽物中の目的物質は培
賽物そのままが,又は遠心分離あるいは培養物に炉過助
剤を加えて戸過して得られた培養液に酢酸エチル,クロ
ロホルム,ベンゼン,トルエン等ノ水ト混和シない有機
溶媒を加えて抽出する。又培養F液を滴宜の担体に接触
させ,P液中の目的有効成分を吸着させ,ついで適当な
溶媒で溶出する事により目的物質を抽出することが出来
る。更に詳しく述べるならば,例えばアンバーライ} 
XAD一2,ダイヤイオンHP−20,ダイヤイオンs
p−900またはダイヤイオンCHP−20Pのごとき
多孔性吸着樹脂,もしくは例えばダウエクス50W,ア
ンバーライトIRC−50というようなイオン交換樹脂
に接触させて目的物質を吸着させる。
To collect the target compound from the culture, extraction, separation, and
Purification means are utilized as appropriate. The target substance in the culture can be obtained by adding ethyl acetate, chloroform, benzene, toluene, etc. to the culture solution obtained by centrifugation or by adding a furnace aid to the culture and passing it through the door. Extract by adding an immiscible organic solvent. In addition, the target substance can be extracted by bringing culture solution F into contact with a suitable carrier to adsorb the target active ingredient in solution P, and then eluting with an appropriate solvent. To be more specific, for example, Amber Rai}
XAD-2, Diamond ion HP-20, Diamond ion s
The target substance is adsorbed by contacting with a porous adsorption resin such as p-900 or Diaion CHP-20P, or an ion exchange resin such as DOWEX 50W or Amberlite IRC-50.

ついで該吸着樹脂の場合にはメタノール,エタノール,
アセトン,アセトニトリル等の有機溶媒と水の混合溶媒
で,該イオン交換樹脂の場合には塩酸,硫酸等の水溶液
で溶出させることにより目的物質含有画分を得ることが
できる。酢酸エチル,酢酸プチル等の有機溶媒で抽出す
る場合には培養戸液にこれらの溶媒を加え,良く振盪し
,目的物質を抽出後,得られた抽出液を酸性水で再抽出
し,目的物質を水に転溶する。
Then, in the case of the adsorption resin, methanol, ethanol,
A fraction containing the target substance can be obtained by elution with a mixed solvent of an organic solvent such as acetone or acetonitrile and water, or in the case of the ion exchange resin with an aqueous solution such as hydrochloric acid or sulfuric acid. When extracting with organic solvents such as ethyl acetate or butyl acetate, add these solvents to the culture solution, shake well, extract the target substance, and re-extract the resulting extract with acidic water to extract the target substance. Dissolve in water.

次いで該酸性水抽出液を中和した後に,該有機溶媒で再
び抽出するという操作を繰り返すことにより,目的物質
のより比率の高い両分を得ることができる。つぎに上記
の各操作法を用いて得られた目的物質含有画分は常用の
吸着処理,例えば活性炭,アルミナ,シリカゲル,セル
ロース等を担体に用いたカラムクロマトグラフィー薄層
クロマトグラフィーや,シリカゲル系ODS逆相担体の
カラムを用いた高速液体クロマトグラフィー等のような
常法により,更に純粋に分離することができる。更にこ
れらの方法で得られた目的物質はメタノール,酢酸エチ
ル等の溶媒で結晶化する事により,一層純粋な物質とし
て得ることができる。このように培養物中に生産された
新規アンスラサイクリン系物質は遊離塩基の形で分離す
ることができる。又この遊離塩基は酸,すなわち例えば
塩酸,硫酸,燐酸等の無機酸,又は例えば蟻酸,酢酸,
クエン酸,酒石酸,p一トルエンスルホン酸等の有機酸
と常法により反応させるとそれぞれの酸に対応する塩類
にも変化させうる。
Next, by repeating the process of neutralizing the acidic water extract and then extracting it again with the organic solvent, it is possible to obtain a higher proportion of the target substance. Next, the target substance-containing fractions obtained using each of the above procedures are subjected to conventional adsorption treatments such as column chromatography, thin layer chromatography using activated carbon, alumina, silica gel, cellulose, etc. as carriers, and silica gel-based ODS. More pure separation can be achieved by conventional methods such as high performance liquid chromatography using a reverse phase carrier column. Furthermore, the target substances obtained by these methods can be crystallized in a solvent such as methanol or ethyl acetate to obtain even purer substances. The new anthracycline substance thus produced in the culture can be separated in the form of its free base. The free base may also be an acid, i.e. an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid, or an inorganic acid such as formic acid, acetic acid,
By reacting with organic acids such as citric acid, tartaric acid, p-toluenesulfonic acid, etc., it can be converted into salts corresponding to the respective acids.

実施例 1. (a)  (YL−01641P−A,物質ノ製造法)
デキストリン2.0%,コーンスチープリカ−0.5%
,ポリペプトン0.5%,酵母エキス0.5%,肉エキ
ス0.3%,プレインハートインフユージョンブイヨン
0.52%,炭酸カルシウム0.5%を含む培地( p
H 8.0 )を作製し,これを500m7三角フラス
コに各60mlずつ分注し,120℃で20分間滅菌し
たものに, ベネット寒天培地上に良《生育させたノカ
ルディアエス・ピー YL−01641p株の菌糸をか
き取って接種し,27゜Cで48時間振盪培養を行ない
種培養液とする。つぎにポテトスターチ3.0%,小麦
胚芽1.0%,コプラミール1。0%,フェザーミール
0.2%,炭酸カルシウム0.5%を含む培地(p}1
7.0)を作成し,これを500+nt三角フラスコに
各60mlずつ分注し,120″Cで20分間滅菌した
ものに,上記培養液を3.0%の割合で植菌し,28℃
で96時間培養した。このようにして得られた培養液1
tにラジオライ} #600 (昭和化学工業社製)を
加えて撹拌した後にF過し,  650m7の培養PH
を得た。このr液をpH7.0とし,酢酸エチルを50
0m4ずつ2回に分けて撹拌し,抽出した。この抽出液
を100mlまで滅菌濃縮し,  100mtの水を加
え,1規定塩酸で水層をpH 2.5に調整し,よく撹
拌して目的物を溶媒層から水に転溶させた。この酸性抽
出液に50m4の酢酸エチルを加え,1規定の苛性ソー
ダで水層をpi{7.5に調整し,よ《撹拌して再抽出
した。この操作を2回繰り返して合計200mZのYL
−0614IP−A,物質の酢酸エチル抽出液を得た。
Example 1. (a) (YL-01641P-A, substance manufacturing method)
Dextrin 2.0%, corn steep liquor - 0.5%
, polypeptone 0.5%, yeast extract 0.5%, meat extract 0.3%, plain heart infusion broth 0.52%, calcium carbonate 0.5% (p
H8.0) was prepared, 60 ml of each was dispensed into 500 m7 Erlenmeyer flasks, and sterilized at 120°C for 20 minutes. The hyphae of the strain were scraped and inoculated, and cultured with shaking at 27°C for 48 hours to prepare a seed culture. Next, a medium containing 3.0% potato starch, 1.0% wheat germ, 1.0% copra meal, 0.2% feather meal, and 0.5% calcium carbonate (p}1
7.0), dispensed 60ml each into 500+nt Erlenmeyer flasks, sterilized them at 120"C for 20 minutes, inoculated them with the above culture solution at a ratio of 3.0%, and incubated at 28°C.
The cells were cultured for 96 hours. Culture solution 1 obtained in this way
Radioly} #600 (manufactured by Showa Kagaku Kogyo Co., Ltd.) was added to t, stirred, filtered through F, and the culture pH of 650 m7 was adjusted.
I got it. Adjust this r solution to pH 7.0 and add 50% ethyl acetate.
The mixture was divided into two portions of 0 m4 each and stirred and extracted. This extract was sterilized and concentrated to 100 ml, 100 mt of water was added, the aqueous layer was adjusted to pH 2.5 with 1N hydrochloric acid, and stirred thoroughly to transfer the target product from the solvent layer into the water. 50 m4 of ethyl acetate was added to this acidic extract, and the aqueous layer was adjusted to pi{7.5 with 1N caustic soda, stirred well, and re-extracted. Repeat this operation twice to obtain a total of 200 mZ YL.
-0614IP-A, an ethyl acetate extract of the substance was obtained.

この抽出液に芒硝を加えてよく脱水した後に芒硝を沢過
して除去し,P液を3 mlまで減圧濃縮して粗YL−
01641P−A,物質の濃縮溶液を得た。物質の確認
にはシリカゲルプレート(キーゼルゲル60F254−
20cmX20cm,  メルク社製)を用い,クロロ
ホルム:メタノール(90:10)の溶媒で展開する薄
層クロマトグラ7イーで目的のYL−01641P A
+物質( Rf = 0.38 >を確認した。このよ
うにして得られた濃縮溶媒中の粗YL−01641P−
A,物質をさらに純粋にするためにシリカゲルプレート
(キーゼルゲル60 F254, 20 cm x 2
Q Cm ,  メルク社製)の3枚に下から2cmの
所に帯状にチャージし,クロロホルム:メタノール(9
0:10)で15cm展開し,風乾した後にUVランプ
と可視光線下でYL−01641PA1物質の赤橙色帯
( Rr = 0.38 )を確認し,この部分をかき
取り,これをクロロホルム:メタノール(90:10)
の溶媒を用いて溶出し,その溶出液を減圧濃縮乾固した
後,少量のメタノールを加え加温溶解し,これを冷蔵庫
中に放置すると針状の結晶が析出したので溶媒を取り除
いた後に,デシケーター中減圧下で一夜乾燥し,純粋な
YL−01641P一A1物質を2.15fllg得た
After adding Glauber's salt to this extract and thoroughly dehydrating, the Glauber's salt was removed by filtration, and the P solution was concentrated under reduced pressure to 3 ml to obtain crude YL-
01641P-A, a concentrated solution of the substance was obtained. To confirm the substance, use a silica gel plate (Kieselgel 60F254-
20cm x 20cm, manufactured by Merck & Co., Ltd.), and the target YL-01641P A was analyzed using thin layer chromatography 7E developed with a solvent of chloroform:methanol (90:10).
+ substance (Rf = 0.38 > was confirmed. Crude YL-01641P- in the concentrated solvent thus obtained
A. Silica gel plate (Kieselgel 60 F254, 20 cm x 2) to further purify the substance.
Q Cm, manufactured by Merck & Co., Ltd.) were charged in a strip at 2 cm from the bottom, and chloroform:methanol (9
0:10), and after air-drying, a red-orange band (Rr = 0.38) of the YL-01641PA1 substance was confirmed under a UV lamp and visible light, and this part was scraped off and mixed with chloroform:methanol ( 90:10)
After the eluate was concentrated to dryness under reduced pressure, a small amount of methanol was added and dissolved by heating. When this was left in the refrigerator, needle-shaped crystals precipitated, so after removing the solvent, Drying in a desiccator under reduced pressure overnight yielded 2.15 fllg of pure YL-01641P-A1 material.

上記抽出,分離,精製されたYL−016 4I P−
A1物質の遊離塩基は下記の物理化学的性質を有する。
The above extracted, separated and purified YL-016 4I P-
The free base of the A1 substance has the following physicochemical properties.

(1)  色および形状:赤色の針状結晶。(1) Color and shape: Red needle-shaped crystals.

(2)酸性,中性,塩基性の区別:塩基性。(2) Distinction between acidic, neutral, and basic: Basic.

(3)  溶解性:メタノール,エタノール,アセトン
,酢酸エチル,ベンゼン,トルエン,クロロホルムには
溶けるが水には溶けに<<,ヘキサンにはほとんど溶け
ない。
(3) Solubility: Soluble in methanol, ethanol, acetone, ethyl acetate, benzene, toluene, and chloroform, but poorly soluble in water, and almost insoluble in hexane.

(4)紫外部吸収スペクトル: YL 01641P 
A+物質のメタノール中で測定した紫外部吸収スペクト
ルは第1図に示すごとくである。
(4) Ultraviolet absorption spectrum: YL 01641P
The ultraviolet absorption spectrum of the A+ substance measured in methanol is as shown in FIG.

(5)  マススペクトル(FAB) : 790 (
 M+ 1 )(6)分子量: 789.831 (力 分子式:C3。H51NOll!(8)元素分析
値: C3o Hs+ NO+。・o,7H20として
C(%)  H(%)  N(%) 実測値 58,30  6.57   1.68計算値
 58,38   6.58   1.75(9)  
’H − NMRスペクトル: YL−01641P 
A+物質の’H−NMRスペクトル( 500 MHz
, CDCI3)は第2図に示すごとくである。
(5) Mass spectrum (FAB): 790 (
M+ 1) (6) Molecular weight: 789.831 (force Molecular formula: C3.H51NOll! (8) Elemental analysis value: C3o Hs+ NO+.・o,7H20 C (%) H (%) N (%) Actual value 58 ,30 6.57 1.68 Calculated value 58,38 6.58 1.75 (9)
'H-NMR spectrum: YL-01641P
'H-NMR spectrum of A+ substance (500 MHz
, CDCI3) are shown in Figure 2.

GO)  13C−NMRスペクトル: YL−016
41P−A,物質の3C−NMRスペクトル(125 
MHz, CDCI,)は第3図に示すごとくである。
GO) 13C-NMR spectrum: YL-016
41P-A, 3C-NMR spectrum of the substance (125
MHz, CDCI,) as shown in Figure 3.

上記の物理化学的性質からYL−01641P A+物
質は下記構造式で示される。
Based on the above physicochemical properties, the YL-01641P A+ substance is represented by the following structural formula.

(b)  塩酸塩の調製法 上記(a)で得られた純粋に精製されたYL−0164
1P一A, 25.6 mgに少量の水を加え,これに
0.5規定の塩酸を注意深く,極く少量ずつ加えながら
良く撹拌しYL−01641P A+物質を溶解した。
(b) Preparation method of hydrochloride Purely purified YL-0164 obtained in (a) above
A small amount of water was added to 25.6 mg of 1P-A, and 0.5N hydrochloric acid was carefully added little by little while stirring well to dissolve the YL-01641P A+ substance.

この操作はYL−01641P−A,物質が完全に溶解
するまで続けた。
This operation was continued until the YL-01641P-A substance was completely dissolved.

この様にして得られたYL−01641P−A,塩酸塩
の水溶液は凍結乾燥し,水に易溶なYL−01641P
 A1の赤色粉末26.761!Igを得た。この物質
の水に対する溶解性は原料のYL−0 164I P−
A,塩基に比較し格段に高い。
The aqueous solution of YL-01641P-A and hydrochloride thus obtained was freeze-dried, and YL-01641P-A, which is easily soluble in water, was
A1 red powder 26.761! Ig was obtained. The solubility of this substance in water is the raw material YL-0 164I P-
A. Much higher than bases.

実施例 2 実施例1に示した方法と同様の培養法で培養したYL−
01641P株の培養液4tに硫酸を加えpH 2.0
に調整した後によ《撹拌した。次いでラジオライ}#6
00(昭和化学工業社製)を加えて再び撹拌した後にF
過した。このF液をpH5.02に調整すると不浴物が
析出して来たのでこれを沢過して2.98tの澄明な培
養r液を得た。このF液をターイヤイオンHP−20(
三菱化成株式会社製)のカラム(60m4・外径2.3
 cm,長さ19cm)に通過させ目的物であるYL−
01641P A+物質を吸着させた後,カラムを1乙
の蒸留水で良《水洗した。次いで, 0.01Mのリン
酸緩衝液を用いて調製した30%, 40%,50%,
60%および70%のアセトン水溶液の各120mlず
つを用いてアセトン濃度の低い順に段階的に溶出した。
Example 2 YL- cultured using the same culture method as that shown in Example 1
Add sulfuric acid to 4 tons of culture solution of 01641P strain to pH 2.0
After adjusting the temperature, stir well. Then Radio Rhy}#6
00 (manufactured by Showa Kagaku Kogyo Co., Ltd.) and stirred again.
passed. When this F solution was adjusted to pH 5.02, unbathable substances precipitated, so much of this was filtered to obtain 2.98 t of clear culture R solution. This F solution was added to Teriyaion HP-20 (
Mitsubishi Kasei Co., Ltd.) column (60 m4, outer diameter 2.3
cm, length 19 cm) to pass through the target object YL-
After adsorbing the 01641P A+ substance, the column was thoroughly washed with 1 liter of distilled water. Next, 30%, 40%, 50%, prepared using 0.01M phosphate buffer.
Elution was carried out stepwise in ascending order of acetone concentration using 120 ml each of 60% and 70% acetone aqueous solutions.

その結果, YL−01641P−A,物質はアセトン
濃度40%および50%の両分に溶出されていた。この
溶出液のYL−01641P A+物質の確認にはシリ
カゲルプレート(キーゼルゲル60 F’254j 2
0 amX20cm,  メルク社製)を用い,クロロ
ホルム:メタノール(90:10)の溶媒で展開する薄
層クロマトグラフィーで目的のYL−01641P−A
,物質(Rf−0.38)を確認した。次いで,このよ
うにして得られたYL−01641P−AI物質の溶出
画分を減圧下で濃縮してYL−01641P−AI物質
(純度34.1%)の赤色粗粉末を1 0 7. 2■
得た。このYL−01641P A+物質の粗粉末を1
00mZの酢酸エチルに溶解した後,P過して不溶物を
取り除き,そのf液に100mlの水を加えてから,振
盪しながら水層を塩酸でpH2.0に調整してYL−0
1641P A+物質を酸性水に逆転抽出した。次いで
,この水溶液を分液して酢酸エチルを除去した後,新た
に10On+7の酢酸エチルを加え,振盪しながら苛性
ソーダーで水層がpH7.0になるように調整し,酢酸
エチル層にYL−01641 P A+物質を転溶せし
めた。次いで,この酢酸エチルの抽出液は分液して水層
を除去し,芒硝を加えてよ《脱水した後,この芒硝をf
過して取り除き,減圧濃縮後乾固して粗YL−01 6
4IP−A,物質(純度41,9%)の赤色粉末を62
.69+11g得た。このようにして得られた粉末に5
m7の水を加え,INの塩酸を少量ずつ加えながら粉末
を完全に溶解した後に,苛性ソーダでpHを5.0に調
整し,粗YL−01641P−A1物質の水石液を調製
した。一方,別に外径1.2 cm×長さ45cmのク
ロマト管に水で充填した30mlのダイヤイオンCHP
−20P (三菱化成株式会社製)のカラムを用意して
おき,これに該粗YL−01641PA,物質の水浴液
を通過させ目的物である−YL−01641P−A,物
質を吸着させた。次いで,このカラムを50mlの水で
洗浄した後,全量が600mt00〜80%アセトン水
を用いた濃度勾配溶出法により溶出を行った。溶出液は
フラクションコレクターで10mlずつに分画した。こ
のように溶出した各フラクションの中で,赤橙色物質が
溶出されている7ラクションは全て,シリカゲルプレー
ト(キーゼルゲル60 F254, 20 cm x 
20 cm,  メルク社製)ヲ用イ,クロロホルム:
メタノール(90:10)の溶媒で展開する薄層クロマ
トグラフィーで目的のYL−01641P−A,物質(
 Rf = 0.38 )を確認した。その結果,目的
物であるYL−01641P−A,物質はフラクション
46〜52までの間に溶出されていた。この中で,最も
純粋であったフラクション48〜50までを集め,減圧
濃縮した後,過飽和の炭酸水素ナトリウム水浴液を過剰
に加えpHを7以上にした後,25mlの酢酸エチルで
二回抽出した。この抽出液に芒硝を加えてよく脱水した
後,P過して芒硝を除去し,このr液を濃縮乾固し,真
空デシケーター中で一夜乾燥してYL−01641 P
−A1物質の赤色粉末(純度86.2%)を25.3[
11g得た。
As a result, the substance YL-01641P-A was eluted at both 40% and 50% acetone concentrations. To confirm the YL-01641P A+ substance in this eluate, use a silica gel plate (Kieselgel 60 F'254j 2
0 am x 20 cm, manufactured by Merck & Co., Ltd.), and the target YL-01641P-A was obtained by thin layer chromatography developed with a solvent of chloroform:methanol (90:10).
, substance (Rf-0.38) was confirmed. Next, the elution fraction of the YL-01641P-AI substance obtained in this manner was concentrated under reduced pressure to obtain 10 7. 2■
Obtained. 1 coarse powder of this YL-01641P A+ substance
After dissolving in 00 mZ of ethyl acetate, insoluble matter was removed by P filtration, 100 ml of water was added to the f solution, and while shaking, the aqueous layer was adjusted to pH 2.0 with hydrochloric acid to dissolve YL-0.
The 1641P A+ material was back-extracted into acidic water. Next, after separating this aqueous solution and removing ethyl acetate, 10 On+7 ethyl acetate was newly added, and while shaking, the aqueous layer was adjusted to pH 7.0 with caustic soda, and YL- was added to the ethyl acetate layer. 01641 P A+ material was transferred. Next, this ethyl acetate extract is separated, the aqueous layer is removed, and mirabilite is added. After dehydration, this mirabilite is
Remove by filtration, concentrate under reduced pressure and dry to give crude YL-01 6
4IP-A, red powder of substance (purity 41.9%)
.. 69+11g was obtained. The powder thus obtained has 5
After adding m7 of water and completely dissolving the powder while adding IN hydrochloric acid little by little, the pH was adjusted to 5.0 with caustic soda to prepare a water stone solution of the crude YL-01641P-A1 material. On the other hand, a chromatography tube with an outer diameter of 1.2 cm and a length of 45 cm was filled with 30 ml of Diaion CHP.
A column of -20P (manufactured by Mitsubishi Kasei Corporation) was prepared, and a water bath solution containing the crude YL-01641PA and substance was passed therethrough to adsorb the target substance, -YL-01641P-A. Next, this column was washed with 50 ml of water, and then elution was carried out by a concentration gradient elution method using 600 mt00-80% acetone water in total. The eluate was fractionated into 10 ml portions using a fraction collector. Among the fractions eluted in this way, all seven fractions in which a reddish-orange substance was eluted were placed on a silica gel plate (Kieselgel 60 F254, 20 cm x
20 cm, manufactured by Merck & Co., Ltd.), chloroform:
The target YL-01641P-A, substance (
Rf = 0.38) was confirmed. As a result, the target substance YL-01641P-A was eluted between fractions 46 and 52. Among these, fractions 48 to 50, which were the purest, were collected and concentrated under reduced pressure. After adding an excess of supersaturated sodium bicarbonate water bath solution to bring the pH to 7 or higher, the mixture was extracted twice with 25 ml of ethyl acetate. . After adding Glauber's salt to this extract and thoroughly dehydrating it, it was filtered through P to remove Glauber's salt, and this r solution was concentrated to dryness, and dried overnight in a vacuum desiccator to obtain YL-01641P.
- Red powder of substance A1 (purity 86.2%) was added at 25.3 [
I got 11g.

実施例 3. グルコース1.0%,ポテトスターチ2.0%,ポリベ
プトン0.5%,酵母エキス0.5%,炭酸カルシウム
0.4%を含む培地a(pa7)を製作し,これを50
0rnlの三角フラスコに100mZずつ分注し,12
0℃で20分間滅菌した。このように作製した培地にペ
ネット寒天上に生育させたノルカディア エス・ヒ− 
YL−01641P株の菌糸をかき取って接種し,27
゜Cで96時間振盪培養を行ない種培養液(1)とする
。つぎに培地A800mtを作製し,これを500rn
l三角フラスコに100mtずつ分注し,120℃で2
0分間滅菌したものに種培養液(1)を2%の割合で植
菌した。これを27゜Cで96時間振盪培養を行ない種
培養i (2)とする。本培養は二基の30t培養槽中
にコブラミール5%,小麦胚芽2.5%,炭酸カルシウ
ム0.15%,消泡剤NKL−5430 (日本油脂社
製) 0.09%を含む生産培地をそれぞれ20t(p
H70)ずつ作製し,予め120゜C,30分間滅菌し
ておき,これにさきに培養しておいた種培養液(2)を
それぞれ400mtずつ接種し,毎分30Lの通気量で
,回転数20Orpmで3日間培養すると, YL−0
1641 P−Al!I質のバチルス ズプチリスAT
CC6633株に対する抗菌活性は最大となった。この
ようにして得られた培養液を塩酸でpH 3.5に調整
した後,ラジオライ} #600 (昭和化学工業社製
)を加えて撹拌した後,P過した。このF液を苛性ソー
ダーでpH7.0に調整し,析出してきた不溶物をf過
して除去し,27tの培養液を得た。このようにして得
たP液よりYL−01641P−A,物質を抽出するた
め,181の酢酸エチルを加え,振盪しながら苛性ソー
タ゜一で培養P液層がpH7.0になるように調整した
Example 3. A medium a (pa7) containing 1.0% glucose, 2.0% potato starch, 0.5% polybeptone, 0.5% yeast extract, and 0.4% calcium carbonate was prepared, and this was
Dispense 100mZ into 0rnl Erlenmeyer flasks, 12
Sterilized at 0°C for 20 minutes. Norcadia S. h. grown on Pennett's agar in the medium prepared in this way.
The hyphae of YL-01641P strain were scraped and inoculated, and 27
The culture was cultured with shaking at °C for 96 hours to obtain a seed culture solution (1). Next, prepare 800 mt of medium A and apply it for 500 mt.
Dispense 100mt into each Erlenmeyer flask and incubate at 120℃ for 2 hours.
After sterilization for 0 minutes, the seed culture solution (1) was inoculated at a rate of 2%. This was cultured with shaking at 27°C for 96 hours, and was designated as seed culture i (2). The main culture was carried out in two 30-ton culture tanks as a production medium containing 5% cobra meal, 2.5% wheat germ, 0.15% calcium carbonate, and 0.09% antifoaming agent NKL-5430 (manufactured by NOF Corporation). 20t (p
H70), sterilized in advance at 120°C for 30 minutes, and inoculated with 400 mt each of the seed culture solution (2) that had been cultivated earlier. When cultured at 20 rpm for 3 days, YL-0
1641 P-Al! Bacillus subtilis AT
The antibacterial activity against CC6633 strain was maximum. After adjusting the pH of the thus obtained culture solution to 3.5 with hydrochloric acid, Radioly #600 (manufactured by Showa Kagaku Kogyo Co., Ltd.) was added and stirred, it was filtered through P. This F solution was adjusted to pH 7.0 with caustic soda, and precipitated insoluble matter was removed by filtration to obtain 27 tons of culture solution. In order to extract the substance YL-01641P-A from the P solution thus obtained, 181 ethyl acetate was added and the culture P solution layer was adjusted to pH 7.0 using a caustic sorter while shaking.

この抽出操作を二回繰り返して行った。YL−0164
1P−A,物質を含む酢酸エチルの抽出液は培養r液層
を分液して除去し,芒硝を加えてよく脱水した後,この
芒硝をF過して取り除き,2lまで減圧濃縮した。これ
にI乙の水を加えてからよく振盪しながら水層を塩酸で
pH 2.0に調整してYL−01641P−A1物質
を酸性水に転溶抽出した。次いで,この水溶液を分液し
て酢酸エチル層を除去した。この操作を二回繰り返して
約2乙のYL−01641P−A,物質の酸性溶液を得
た。新たに1乙の酢酸エチルを加え,振盪しながら苛性
ソーダーで水層がpI{7.0になるように調整し,酢
酸エチル層にYL−01641P −A1物質を抽出せ
しめた後,分液して水層を除去した。この操作を二回繰
り返して約26のYL−01641P−A,物質を含む
酢酸エチルの抽出液を得た。次いで,この酢酸エチルの
抽出液に芒硝を加えてよく脱水した後,芒硝をF過して
取り除き,減圧濃縮後乾固して粗YL−01641P 
A+物質の赤色粉末を43611@得た。この粗YL−
01641P At物質の赤色粉末の153■を取り,
これに2 mlのメタノールな加えて溶解した。このメ
タノール浴液を0.4mlずつに分け,液体クロマトグ
ラフィーにがげYL−01641P−A,物質を汁取;
た。液体クロマトグラフィーの条件はYMC−Pack
 R−ODS−5 (山村化学研究所社製)の2cmX
25cmカラムに,溶Ni液として0.05Mリン酸緩
衝液( pI{4.35 ) :アセトニトリル:テト
ラヒド口フラン(75 : 10 : 15)を毎分9
1+17の流.量割合で流して用い,480nmのUV
吸収を検出に用いた。その結果,  YL−01641
P−AI物質は保持時間15分48秒に溶出されたので
,この画分を集めた。
This extraction operation was repeated twice. YL-0164
The ethyl acetate extract containing the substance 1P-A was removed by separating the culture liquid layer, thoroughly dehydrated by adding Glauber's salt, filtered through F to remove the Glauber's salt, and concentrated under reduced pressure to 2 liters. After adding I-B of water to this, the aqueous layer was adjusted to pH 2.0 with hydrochloric acid while shaking well, and the YL-01641P-A1 substance was extracted by dissolving into the acidic water. Next, this aqueous solution was separated and the ethyl acetate layer was removed. This operation was repeated twice to obtain about 2 volumes of an acidic solution of YL-01641P-A. Add 1 part of ethyl acetate and adjust the aqueous layer to pI{7.0 with caustic soda while shaking. After extracting the YL-01641P-A1 substance to the ethyl acetate layer, separate the layers. The aqueous layer was removed. This operation was repeated twice to obtain an ethyl acetate extract containing about 26 YL-01641P-A substances. Next, after adding Glauber's salt to this ethyl acetate extract and thoroughly dehydrating, Glauber's salt was removed by F filtration, concentrated under reduced pressure, and dried to give crude YL-01641P.
43611@ of red powder of A+ substance was obtained. This coarse YL-
01641P Take 153■ of red powder of At material,
To this, 2 ml of methanol was added and dissolved. Divide this methanol bath solution into 0.4 ml portions, transfer to liquid chromatography YL-01641P-A, and extract the substance;
Ta. Liquid chromatography conditions are YMC-Pack
2cmX of R-ODS-5 (manufactured by Yamamura Kagaku Kenkyusho Co., Ltd.)
0.05M phosphate buffer (pI{4.35):acetonitrile:tetrahydrofuran (75:10:15) was added to a 25cm column as a Ni solution at a rate of 9/min.
1+17 style. 480nm UV
Absorption was used for detection. As a result, YL-01641
Since the P-AI substance was eluted at a retention time of 15 minutes and 48 seconds, this fraction was collected.

この画分は液体クロマトグラフィー(カラム:YMC−
PackA 312 ( S−5120−ODS ) 
(山村化学研究所社製) 6mm x 150mm,溶
離液:0.05Mリン酸緩衝液( pH4.35 ) 
:アセトニトリル:テトラヒド口フラン(70: 15
: 15), @出量:毎分当たり1ml,保持時間=
5分51秒)で純粋であることを確認1−だ後,減圧濃
縮して溶出液中の有機溶媒をよく蒸発させて取り除いた
。このように処理した溶出液(約120m7)に過剰の
炭酸水素ナトリウム溶液を加えpH 7.0以上に調製
し,100mlの酢酸エチルを加えて抽出を行った。こ
の抽出操作を二回繰り返して約200mtのYL−01
641P−A,物質の酢敢エチル溶液を得た。この溶液
に芒硝を加えてよく脱水した後,この芒硝をF過じて取
り除き,減圧濃縮乾固し,更に真空デシケーター中で一
夜乾燥して純粋なYL−01641P−A,物質の赤色
粉末を83■得た。この粉末の40.0111gを取り
,1+++7の水を加えた後,赤色粉末が完全に溶解す
るまで0.5%の酒石酸水浴液を少量ずつ滴下しながら
よく撹拌した。
This fraction was subjected to liquid chromatography (column: YMC-
PackA 312 (S-5120-ODS)
(Manufactured by Yamamura Kagaku Kenkyusho Co., Ltd.) 6 mm x 150 mm, eluent: 0.05M phosphate buffer (pH 4.35)
: Acetonitrile: Tetrahydrofuran (70: 15
: 15), @output amount: 1ml per minute, retention time =
After confirming that the eluate was pure (1-5 minutes and 51 seconds), it was concentrated under reduced pressure to thoroughly evaporate and remove the organic solvent in the eluate. Excess sodium bicarbonate solution was added to the eluate treated in this way (approximately 120 m7) to adjust the pH to 7.0 or higher, and 100 ml of ethyl acetate was added to perform extraction. This extraction operation was repeated twice to obtain approximately 200 mt of YL-01.
641P-A, a solution of the substance in ethyl acetate was obtained. After adding Glauber's salt to this solution and thoroughly dehydrating, the Glauber's salt was removed by F filtration, concentrated to dryness under reduced pressure, and further dried overnight in a vacuum desiccator to obtain pure YL-01641P-A, a red powder of 83% ■I got it. 40.0111 g of this powder was taken, 1+++7 g of water was added thereto, and 0.5% tartaric acid water bath solution was added dropwise little by little with stirring until the red powder was completely dissolved.

この時YL−01641P A+物質が完全に溶解した
時点のpHは4.53であった。このように調製して得
られたYL−0164 IP−A,物質の酒石酸水溶液
を凍結乾燥して純粋なYL−01641P−A,物質の
酒石酸塩の結晶性粉末を42.61I1g得た。本酒石
酸塩は水に対する溶解度が原料であるYL−01641
P−A,物質の遊離塩基に比べて格段に高い。
At this time, the pH at the time when the YL-01641P A+ substance was completely dissolved was 4.53. The tartaric acid aqueous solution of the YL-0164 IP-A substance thus prepared was freeze-dried to obtain 42.61I1g of pure YL-01641P-A tartrate crystalline powder. The solubility of this tartrate in water is the raw material YL-01641.
P-A, which is significantly higher than the free base of the substance.

実施例4. (YL−01641P−A2,B2および
B,の製造法)[A]  グルコース1.0%,ポテト
スターチ2.0%,ポリペプトン05%,酵母エキス0
.5%,炭酸カルシウム0.4%を含む培地A(pH7
)を作製し,これを500mlの三角フラスコに100
mZずつ分注し,120゜Cで20分間滅菌した。この
ように作製した培地にベネ,ト寒天上に生育させたノカ
ルディア エス・ピーYL−01641P株の菌糸をか
き取って接種し,27℃で96時間振盪培養を行い種培
養液(1)とする。
Example 4. (Production method of YL-01641P-A2, B2 and B) [A] Glucose 1.0%, potato starch 2.0%, polypeptone 05%, yeast extract 0
.. Medium A (pH 7) containing 5% calcium carbonate and 0.4% calcium carbonate.
) and put 100ml of this into a 500ml Erlenmeyer flask.
The solution was dispensed into mZ portions and sterilized at 120°C for 20 minutes. The mycelium of Nocardia SP YL-01641P strain grown on Benet agar was scraped and inoculated into the medium thus prepared, and cultured with shaking at 27°C for 96 hours to form a seed culture solution (1). do.

次に培地A800mlを作製し,これを500 rnl
三角フラスコに100Intずつ分注し,120℃で2
0分間滅菌したものに種培養液(1)を2%の割合で植
菌した。これを27℃で96時間振盪培養を行い種培養
液(2)とする。本培養は30t培養槽中にコプラミー
ル5%,小麦胚芽2.5%,炭酸カルシウム0.15%
,消泡剤NKL−5430 ( 日本油脂社製)0.0
9%を含む生産培地21(pH7.0)を作製し,予メ
l20’c, 30分間滅菌しておき,これに先に培養
しておいた種培養液[B] (2) 400 rnlを接種し,通気量毎分30t,
回転数20O rpmで2日間培養し,培養物19Lを
得た。
Next, prepare 800 ml of medium A and add it to 500 rnl.
Dispense 100 Int into each Erlenmeyer flask and incubate at 120℃ for 2 hours.
After sterilization for 0 minutes, the seed culture solution (1) was inoculated at a rate of 2%. This was cultured with shaking at 27° C. for 96 hours to obtain a seed culture solution (2). The main culture was carried out in a 30t culture tank with 5% copra meal, 2.5% wheat germ, and 0.15% calcium carbonate.
, Antifoaming agent NKL-5430 (manufactured by NOF Corporation) 0.0
Prepare a production medium 21 (pH 7.0) containing 9%, sterilize it in advance for 30 minutes, and add 400 rnl of the seed culture solution [B] (2) cultured previously to this. Inoculation, aeration rate 30t/min,
Culture was carried out for 2 days at a rotation speed of 200 rpm to obtain 19 L of culture.

上記培養物19tを塩酸でpH3.5に調整した後,ラ
ジオライト#600 (昭和化学工業社製)を加えて攪
拌した後,f′1過し15tの培養f液を得た。このf
液から該目的物質を抽出するため107の酢酸エチルを
加え振盪しながら苛性ンーダーで培養f液層がpH7.
0になるように調整し,酢酸エチル層に該目的物質を抽
出せしめ,その抽出操作を二回繰り返して行った。この
該目的物質を含む酢酸エチルの抽出液から培養f液層を
分液して除去し,芒硝を加えてよく脱水した後,芒硝を
沢過して取り除き2tまで減圧濃縮した。これに1tの
水を加え振盪しながら水層を塩酸でPH2.0に調整し
て該目的物質を酸性水に転溶抽出した。次いでこの水溶
液を分液して酢酸エチル層を除去した。この操作を二回
繰り返して約2tの該目的物質の酸性水溶液を得た。
After adjusting the pH of 19 tons of the above culture to 3.5 with hydrochloric acid, Radiolite #600 (manufactured by Showa Kagaku Kogyo Co., Ltd.) was added and stirred, the mixture was filtered through f'1 to obtain 15 tons of culture solution f. This f
In order to extract the target substance from the solution, 107 ethyl acetate was added and the culture liquid layer was adjusted to pH 7.
The target substance was extracted into the ethyl acetate layer, and the extraction operation was repeated twice. The culture f liquid layer was separated and removed from the ethyl acetate extract containing the target substance, and after thoroughly dehydrating by adding Glauber's salt, much of the Glauber's salt was removed and concentrated under reduced pressure to 2 tons. 1 ton of water was added to this, and while shaking, the aqueous layer was adjusted to pH 2.0 with hydrochloric acid, and the target substance was extracted by dissolution into acidic water. Next, this aqueous solution was separated and the ethyl acetate layer was removed. This operation was repeated twice to obtain about 2 tons of an acidic aqueous solution of the target substance.

新たに1tの酢酸エチルを加え,振盪しなが[C] ら苛性ソーダーで水層がpH7.0になるように調整し
,酢酸エチル層に該目的物質を抽出せしめた後,分液し
て水層を除去した。この操作を二回繰り返して約26の
該目的物質を含む酢酸エチルの抽出液を得た。次いで,
この酢酸エチルの抽出液に芒硝を加えてよく脱水した後
,芒硝を沢過して取り除き減圧濃縮後,乾固して粗目的
物質を含む粗製品30211gを得た。
Add another 1 t of ethyl acetate, and while shaking, adjust the aqueous layer to pH 7.0 with caustic soda. After extracting the target substance into the ethyl acetate layer, separate the layers. The aqueous layer was removed. This operation was repeated twice to obtain an ethyl acetate extract containing about 26 target substances. Next,
After adding Glauber's salt to this ethyl acetate extract and thoroughly dehydrating, the sodium sulfate was thoroughly filtered off, concentrated under reduced pressure, and dried to obtain 30,211 g of a crude product containing the crude target substance.

上記粗製品302■を5 mlのメタノールに溶解し,
このメタノール溶液0.5mlずつを液体クロマトグラ
フィーにかけ保持時間の相違により3種の目的物質を分
取した。分取液体クロマトグラフィーの条件はSTR−
PREP ODSH(島津テクノリサーチ社製)の2c
mX2Scmカラム,溶離液として0.02Mリン酸緩
衝液(pH4.2) :アセトニトリル:テト2ヒドロ
フラン:メタノール(67:15:8:10)を毎分7
 mlの流量割合で流して用い,  254nmのUV
吸収を検出に用いた。
Dissolve 302■ of the above crude product in 5 ml of methanol,
0.5 ml each of this methanol solution was subjected to liquid chromatography to separate three types of target substances based on differences in retention time. The conditions for preparative liquid chromatography are STR-
PREP ODSH (manufactured by Shimadzu Techno Research) 2c
mX2Scm column, 0.02M phosphate buffer (pH 4.2):acetonitrile:tetrihydrofuran:methanol (67:15:8:10) as eluent at 7 min.
ml flow rate, 254 nm UV
Absorption was used for detection.

分取画分中の該目的物質の確認にはシリカゲルプレート
(キーゼルゲル60F254+ 20cmX20cm,
メルク社製)を用い,クロロホルム:酢酸エチル:メタ
ノール:アンモニア水(70:30:10:0.1)の
溶媒で展開する薄層クロマトグラフイーな用いた。更に
,各分取画分は分析用カラムを用いた液体クロマトグラ
フィー(条件:分析用カラムSTR −ODS −H 
4.6 mm X250mm(島津テクノリサーチ社製
),溶離液0.02Mリン酸緩衝液(pH4.2):ア
セトニトリル:テトラヒドロフラン:メタノール(65
:15:10:10),溶出量毎分当たり0.8ml)
で分析を行い該目的物質が純粋であることを確認した。
To confirm the target substance in the preparative fraction, use a silica gel plate (Kieselgel 60F254+ 20cm x 20cm,
Merck & Co., Ltd.) was used, and thin layer chromatography was used, developed with a solvent of chloroform:ethyl acetate:methanol:aqueous ammonia (70:30:10:0.1). Furthermore, each fraction was subjected to liquid chromatography using an analytical column (conditions: analytical column STR-ODS-H).
4.6 mm
:15:10:10), elution volume 0.8ml/min)
It was confirmed that the target substance was pure.

■ 分取液体クロマトグラフィーで保持時間14分48
秒に溶出された画分から得られた目的物質:この物質は
,上記薄層クロマトグラフィーにおけるRf値が0.1
7,また上記分析用力ラムを用いた液体クロマトグラフ
ィーの保持時間が5分31秒を示す単一物である。この
画分の溶出液中の有機溶媒を減圧濃縮して取り除いた後
,炭酸水素ナトリウム溶液を加えpHを70以上に調整
後酢酸エチルで抽出し,抽出液に芒硝を加えてよく脱水
した後,芒硝を沢過して取り除き減圧濃縮乾固し,更に
真空デシケーター中で一夜乾燥した。得られた赤色粉末
(8.0[I1g)は,つぎの物理化学的性質を示す。
■ Retention time by preparative liquid chromatography: 14 minutes 48 minutes
Target substance obtained from the fraction eluted in seconds: This substance has an Rf value of 0.1 in the thin layer chromatography described above.
7. It is also a single substance whose retention time in liquid chromatography using the analytical ram described above is 5 minutes and 31 seconds. After the organic solvent in the eluate of this fraction was removed by concentration under reduced pressure, sodium hydrogen carbonate solution was added to adjust the pH to 70 or higher, and the mixture was extracted with ethyl acetate. After adding Glauber's salt to the extract and thoroughly dehydrating, Glauber's salt was removed by filtration, concentrated to dryness under reduced pressure, and further dried overnight in a vacuum desiccator. The obtained red powder (8.0 [I1 g) exhibits the following physicochemical properties.

(1)色および形状:赤色の針状結晶。(1) Color and shape: red needle-like crystals.

(2)酸性,中性,塩基性の区別:塩基性。(2) Distinction between acidic, neutral, and basic: Basic.

(3)溶解性:メタノール,エタノール,アセトン,酢
酸エチル,ベンゼン,トルエン,クロロホルムには溶け
るが水には溶けに<<,ヘキサンにはほとんど溶けない
(3) Solubility: Soluble in methanol, ethanol, acetone, ethyl acetate, benzene, toluene, and chloroform, but poorly soluble in water, and almost insoluble in hexane.

(4)紫外部吸収スペクトル: YL−01641P−
A2化合物のメタノール中で測定した紫外部吸収スペク
トルは第4図で示すごとくである。
(4) Ultraviolet absorption spectrum: YL-01641P-
The ultraviolet absorption spectrum of the A2 compound measured in methanol is as shown in FIG.

(5)  マススペクトル(FAB):748(M+1
)(6)  分子量:747.792 (力 分子式: C37H411NO+5(8)  ’
H−NMRスペクトル: YL−01641P−A2化
合物の’H−NMRスペクトル(500MHz,CDC
I,)は第5図に示すごとくである。
(5) Mass spectrum (FAB): 748 (M+1
)(6) Molecular weight: 747.792 (force Molecular formula: C37H411NO+5(8)'
H-NMR spectrum: 'H-NMR spectrum of YL-01641P-A2 compound (500MHz, CDC
I,) is as shown in FIG.

上記物理化学的性質から,本物質は,下記構造式で示さ
れるYL−01641P−A2物質である。
Based on the above physicochemical properties, this substance is YL-01641P-A2 substance shown by the following structural formula.

■ 分取液体クロマトグラフィーで保持時間31分30
秒に溶出された画分から得られた目的物質: この物質は薄層クロマトグラフィーにおけるRf値が0
.15,また上記分析用カラムを用いた液体クロマトグ
ラフィーの保持時間が10分14秒を示す単一物である
。この画分を上記の?法と同様に抽出,濃縮,乾燥して
得られた暗赤色粉末(671′rlg)は,つぎの物理
化学的性質を示す。
■ Retention time by preparative liquid chromatography: 31 minutes 30 minutes
Target substance obtained from the fraction eluted in seconds: This substance has an Rf value of 0 in thin layer chromatography.
.. 15, is a single substance whose retention time in liquid chromatography using the above analytical column was 10 minutes and 14 seconds. This fraction above? The dark red powder (671'rlg) obtained by extraction, concentration, and drying in the same manner as in the method shows the following physicochemical properties.

(1)  色および形状:暗赤色の針状結晶。(1) Color and shape: dark red needle-like crystals.

(2)酸性,中性,塩基性の区別:塩基性。(2) Distinction between acidic, neutral, and basic: Basic.

(3)溶解性:メタノール,エタノール,アセトン,酢
酸エチル,ベンゼン,トルエン,クロロホルムには溶け
るが水には溶けに<<,ヘキサンにはほとんど溶けない
(3) Solubility: Soluble in methanol, ethanol, acetone, ethyl acetate, benzene, toluene, and chloroform, but poorly soluble in water, and almost insoluble in hexane.

(4)紫外部吸収スペクトル: YL−01641P 
一B2化合物のメタノール中で測定した紫外部吸収スペ
クトルは第6図に示すごとくである。
(4) Ultraviolet absorption spectrum: YL-01641P
The ultraviolet absorption spectrum of the B2 compound measured in methanol is shown in FIG.

(5)  マススペクトル(FAB):734(M+1
)(6)分子量:733.765 (7)分子式: C36H,■NO ,,(81  ’
H−NMRスペクトル: YL−01641P−B2化
合物の’H−NMRスペクトル(500MHz,CDC
I,)は第7図に示すごとくである。
(5) Mass spectrum (FAB): 734 (M+1
) (6) Molecular weight: 733.765 (7) Molecular formula: C36H, ■NO ,, (81'
H-NMR spectrum: 'H-NMR spectrum of YL-01641P-B2 compound (500MHz, CDC
I,) is as shown in FIG.

上記の物理化学的性質から,本物質は,下記構造式で示
されるYL 01641P−B2物質である。
Based on the above physicochemical properties, this substance is YL 01641P-B2 substance shown by the following structural formula.

■ 分取液体クロマトグラフイーで保持時間47分45
秒に溶出された画分から得られた目的物質: この物質は,上記薄層クロマトグラフイーにおけるRf
値が0.28,また,上記分析用カラムを用いた液体ク
ロマトグラフイーの保持時間が16分08秒を示す単一
物である。この画分を上記の方法と同様に抽出,濃縮,
乾燥して得られた暗赤色粉末(69.801g)は,つ
ぎの性質を示す。
■ Retention time using preparative liquid chromatography: 47 minutes 45 minutes
Target substance obtained from the fraction eluted in seconds: This substance was detected by the Rf
It is a single substance with a value of 0.28 and a retention time of 16 minutes and 08 seconds in liquid chromatography using the above analytical column. This fraction was extracted, concentrated, and
The dark red powder (69.801 g) obtained by drying exhibits the following properties.

(l)色および形状:暗赤色の針状結晶。(l) Color and shape: dark red needle-like crystals.

(2)酸性,中性,塩基性の区別:塩基性。(2) Distinction between acidic, neutral, and basic: Basic.

(3)溶解性:メタノール,エタノール,アセトン,酢
酸エチル,ベンゼン,トルエン,クロロホルムには溶け
るが水には溶けに<<,ヘキサンにはほとんど溶けない
(3) Solubility: Soluble in methanol, ethanol, acetone, ethyl acetate, benzene, toluene, and chloroform, but poorly soluble in water, and almost insoluble in hexane.

(4)紫外部吸収スペクトル: YL−01641P−
B,化合物のメタノール中で測定した紫外部吸収スペク
トルは第8図に示すごとくである。
(4) Ultraviolet absorption spectrum: YL-01641P-
B. The ultraviolet absorption spectrum of the compound measured in methanol is shown in FIG.

(5)  マススペクトル(FAB):776(M+1
)(6)分子量:775.802 (力 分子式二C38 H49 No le(8)  
用一NMRスペクトルニYL−01641P−B,化合
物の用−NMRスペクトル(500MHz,C D C
 1 3)は第9図に示すごとくである。
(5) Mass spectrum (FAB): 776 (M+1
) (6) Molecular weight: 775.802 (force molecular formula 2 C38 H49 No le (8)
NMR spectrum for compound YL-01641P-B, NMR spectrum for compound (500MHz, CD C
13) as shown in FIG.

(9)  13C−NMRスペクトル: YL−016
41P−B,化合物の13C − NM Rスペクトル
(125MHz,CDCI3)は第10図に示すごとく
である。
(9) 13C-NMR spectrum: YL-016
The 13C-NMR spectrum (125 MHz, CDCI3) of the compound 41P-B is as shown in FIG.

上記物埋化学的性質から,本物質は,下記構造式で示さ
れるYL−01641P−B,物質である。
From the above chemical properties, this substance is YL-01641P-B, a substance represented by the following structural formula.

[D] YL−01641P−A2 3[flg,YL−016
41P−B231I1g, YL−01641P−B,
 30■を取り,適宜,水を加えた後,粉末が完全に溶
解するまで0.5%の酒石酸水溶液を少量ずつ滴下しな
がら加えた。この時,該化合物が完全に溶解した時点の
pHは, pH4.5からpH4.6であった。
[D] YL-01641P-A2 3[flg, YL-016
41P-B231I1g, YL-01641P-B,
After adding water as needed, 0.5% tartaric acid aqueous solution was added dropwise little by little until the powder was completely dissolved. At this time, the pH at the time when the compound was completely dissolved was from pH 4.5 to pH 4.6.

このように調整して得られた該化合物の酒石酸水溶液を
凍結乾燥して純粋なYL−0164LP−A2酒石酸塩
3.17111g, YL−01641P−82酒石酸
塩3.17■,YL−01641P−B,酒石酸塩31
.68■を得た。本酒石酸塩は水に対する溶解度が原料
である該化合物の遊離塩基に比べて格段に高い。
The tartaric acid aqueous solution of the compound thus prepared was freeze-dried to obtain 3.17111 g of pure YL-0164LP-A2 tartrate, 3.17 g of YL-01641P-82 tartrate, YL-01641P-B, tartrate 31
.. I got 68■. The solubility of the tartrate in water is much higher than that of the free base of the compound as a raw material.

実施例 5  (YL−01641P  C+物質の製
造)実施例3と同様の方法で種培養液(11に続き種培
養液(2)を作製する。別に306培養槽に同様の種培
地を作製し,滅菌しておき,これに種培養液(2)を4
00ml接種した後,毎分30 tの通気量で回転数2
00 rpmで72時間培養し種培養液(3)とする。
Example 5 (Manufacture of YL-01641P C+ substance) Seed culture solution (following 11, prepare seed culture solution (2)) in the same manner as in Example 3. Separately, prepare a similar seed culture medium in a 306 culture tank, Sterilize it and add 4 seeds of the seed culture solution (2) to it.
After inoculating 00ml, the rotation speed was 2 at an aeration rate of 30 t/min.
00 rpm for 72 hours to prepare a seed culture solution (3).

本培養は,実施例3における本培養と同じ培地を230
t作成し,120°C,45分間滅菌しておき,これに
先の種培養液(3)を4t接種した。この後,毎分15
0Lの通気量で回転数75rpmで3日間培養するとY
L−016411−C,物質のバチルスズブチリスAT
CC6633株に対する抗菌活性は最大となった。
For the main culture, the same medium as the main culture in Example 3 was used at 230%
t was prepared, sterilized at 120°C for 45 minutes, and 4 t of the above seed culture solution (3) was inoculated into this. After this, 15 per minute
When cultured for 3 days at a rotation speed of 75 rpm with an aeration volume of 0 L, Y
L-016411-C, substance Bacillus subtilis AT
The antibacterial activity against CC6633 strain was maximum.

この様にして得られた培養液を塩酸でpH 2.0に調
整した後,ラジオライト#600(昭和化学工業社製)
を加えて攪拌した。1時間後に,この培養液を戸過して
固形物を除去し,得られた培養液に1規定の苛性ソーダ
ー溶液を加え,  pHを7.0に調整した。この際不
溶物が析出してくるので,このP液を再度戸過し,不溶
物を除いて澄明な戸液を205t得た。この様にして得
られた培養液からYL−1641P  C1を抽出する
ため,あらかじめ30cmX150cmのガラス塔に用
意しておいた20tのダイアイオンHP−20 (三菱
化成株式会社製)のカラムSV = 2.5の割合で通
過せしめ, YL01641P−C,物質を吸着させた
。次いでこのカラムを良く水洗した後,30%アセトン
水41.60%アセトン水601.60%アセトン−0
.05M緩衝溶液60tを段階的に流し,目的物である
YL−01641Pの溶出を行った。目的物の検出は薄
層クロマトグラフィー(キーゼルゲル60F2!,42
0の×20の(メルク社製),展開溶媒;クロロホルム
:酢酸エチル:メタノール=28%アンモニア水(70
:30:10:0.1),目的物YL−01641P 
C+ORf値:0.3)を用いて行った。その結果,目
的物のYL− 01641 P−C,は60%アセトン
水溶出以降の溶出画分の80t中に含まれていた。この
溶出液は約3OLまで濃縮し,アセトンを除去した後,
20tの酢酸エチルを加え,振盪しながら苛性ソーダで
水層のpHが7.0  になる様に調整し,酢酸エチル
層に目的物であるYL−01641p−c,を抽出した
。この酢酸エチルによる抽出操作を2回操り返して行っ
た。この様にして得られた酢酸エチル溶液は約3tまで
減圧濃縮した後,2tの水を加えよく振盪しながら水層
のpHが2.0になるまで塩酸を加え,目的物のYL−
01641P C宜 を酸性水に転溶抽出した。この操
作を2回繰り返して4乙の目的物を含む酸性水溶液を得
た。この水溶液に新たに26の酢酸エチルを加え,振盪
しながら苛性ノーダーでpHを7,2に調整し,酢酸エ
チル層に目的物のYL−01641P−Cを再抽出せし
めた。
After adjusting the pH of the culture solution thus obtained to 2.0 with hydrochloric acid, it was added to Radiolite #600 (manufactured by Showa Kagaku Kogyo Co., Ltd.).
was added and stirred. After 1 hour, the culture solution was filtered to remove solid matter, and 1N caustic soda solution was added to the obtained culture solution to adjust the pH to 7.0. At this time, insoluble matter precipitated, so this P solution was filtered again to remove the insoluble matter and obtain 205 tons of clear solution. In order to extract YL-1641P C1 from the culture solution obtained in this way, a 20 t Diaion HP-20 (manufactured by Mitsubishi Kasei Corporation) column SV = 2. 5 to adsorb the substance YL01641P-C. Next, after thoroughly washing this column with water, 30% acetone water 41.60% acetone water 601.60% acetone-0
.. 60 t of 05M buffer solution was flowed stepwise to elute the target product YL-01641P. Detection of the target substance was performed using thin layer chromatography (Kieselgel 60F2!, 42
0 x 20 (manufactured by Merck & Co.), developing solvent; chloroform: ethyl acetate: methanol = 28% aqueous ammonia (70
:30:10:0.1), target YL-01641P
C+ORf value: 0.3). As a result, the target product YL-01641P-C was contained in 80t of eluted fractions after 60% acetone water elution. This eluate was concentrated to about 3 OL, and after removing acetone,
20 tons of ethyl acetate was added, and while shaking, the pH of the aqueous layer was adjusted to 7.0 with caustic soda, and the target product, YL-01641p-c, was extracted into the ethyl acetate layer. This extraction operation with ethyl acetate was repeated twice. The ethyl acetate solution obtained in this way was concentrated under reduced pressure to about 3 tons, then 2 tons of water was added, and while shaking well, hydrochloric acid was added until the pH of the aqueous layer became 2.0.
01641PC was transferred and extracted into acidic water. This operation was repeated twice to obtain an acidic aqueous solution containing 4 target substances. 26 ethyl acetate was newly added to this aqueous solution, the pH was adjusted to 7.2 with a caustic nodder while shaking, and the target product YL-01641P-C was re-extracted from the ethyl acetate layer.

この操作を2度繰り返し約4tの目的物を含む酢酸エチ
ル抽出液を得た。目的物の検出には上記薄層クロマトグ
ラフィーを各抽出段階において用い認した。この様にし
て抽出した目的物であるYL01641P−C,を含む
酢酸エチル溶液は芒硝で脱水し,減圧下40℃で濃縮し
た後,乾固し,デシケーター中で一夜良く乾燥し,88
gのYL−01641P C+を含む粗粉末を得た。こ
の粗粉末に50mlの水を加え,粉末が完全に溶解する
まで塩酸を加え,目的物YL−01641P−C,を含
む水溶液を調製した。この溶液を予め4crn×115
CrrLのガラス管にダイヤイオンHP−20(三菱化
成株式会社製)の16を詰め,良《水洗し,用意してお
いた力ラムにSv=o2の割合でチャージし,吸着させ
た。吸着後よく水洗した後,  30〜60%アセトン
水(合計86)の濃度勾配溶出法で溶出し,溶出液は1
6gを1分画としてフラクションコレクターで分画した
。溶出液中の目的物は上記薄層クロマトグラフィーによ
り確認した。その結果,フラクションナンバー341〜
385の中に目的物が含まれていたので,この両分を集
め減圧下40゜Cで濃縮してアセトンを除去した後,こ
の濃縮液と同量の酢酸エチルを加え,水層をpH7.2
に調整しながら目的物を抽出した。この操作を2回繰り
返した。この抽出液を芒硝で脱水し,減圧下40℃で濃
縮乾固し,真空デシケーター中で一夜乾燥し,目的物Y
L−01641P−C,の粗粉末を3.0 g得た。こ
の粗粉末の1.0 gに2mlの水を加え,l規定の塩
酸を少しずつ加えて完全に溶解した。この溶解液の10
0μtつづを液体クロマトグラフィーにかげ分取した。
This operation was repeated twice to obtain an ethyl acetate extract containing about 4 tons of the target product. The target product was detected using the thin layer chromatography described above at each extraction step. The ethyl acetate solution containing YL01641P-C, the target product extracted in this way, was dehydrated with Glauber's salt, concentrated under reduced pressure at 40°C, dried, and thoroughly dried in a desiccator overnight.
A coarse powder containing g of YL-01641P C+ was obtained. 50 ml of water was added to this crude powder, and hydrochloric acid was added until the powder was completely dissolved to prepare an aqueous solution containing the target product YL-01641P-C. Add this solution in advance to 4crn x 115
A CrrL glass tube was filled with Diaion HP-20 (manufactured by Mitsubishi Kasei Corporation) No. 16, washed with water, and charged into a prepared power ram at a ratio of Sv=o2 for adsorption. After adsorption and thorough washing with water, elution was performed using a concentration gradient elution method using 30-60% acetone water (86% in total).
One fraction of 6 g was fractionated using a fraction collector. The target substance in the eluate was confirmed by the thin layer chromatography described above. As a result, fraction number 341~
Since the target substance was contained in 385, both of these fractions were collected and concentrated under reduced pressure at 40°C to remove acetone, and then the same amount of ethyl acetate as this concentrated solution was added, and the aqueous layer was brought to pH 7. 2
The target product was extracted while adjusting the This operation was repeated twice. This extract was dehydrated with Glauber's salt, concentrated to dryness under reduced pressure at 40°C, dried overnight in a vacuum desiccator, and the target product Y
3.0 g of coarse powder of L-01641P-C was obtained. 2 ml of water was added to 1.0 g of this crude powder, and 1N hydrochloric acid was added little by little to completely dissolve it. 10 of this solution
A 0 μt aliquot was fractionated using liquid chromatography.

この時の液体クロマトグラフィーの条件は, STR−
PF!EP ODS−H (島津テクノリサーチ社製)
の2α×25カラムを用い,溶離液は0.02MIJン
酸緩衝液(pH4.2) :アセトニトリル:メタノー
ル(75:15:10)を毎分8mlの割合で溶出し,
  254nmのUV検出を用いた。この様にして保持
時間21分6秒に溶出されてきた目的物YL−0164
1P C+ ノ画分を集め,減圧下40’Cで濃縮し,
有機溶媒を除去した後,この濃縮液と同量の酢酸エチル
を加え,水層のpHが7.5以上になる様に炭酸水素ナ
トリウム溶液を加えて良く振盪し,目的化合物YL− 
01641P−C,物質を酢酸エチル層に抽出せしめた
。この抽出操作は2回繰り返した。
The liquid chromatography conditions at this time were STR-
PF! EP ODS-H (manufactured by Shimadzu Techno Research)
Using a 2α x 25 column of
UV detection at 254 nm was used. In this way, the target product YL-0164 was eluted at a retention time of 21 minutes and 6 seconds.
The 1P C+ fraction was collected and concentrated at 40'C under reduced pressure.
After removing the organic solvent, add the same amount of ethyl acetate as this concentrated solution, add sodium hydrogen carbonate solution so that the pH of the aqueous layer becomes 7.5 or higher, and shake well to obtain the target compound YL-
01641P-C, material was extracted into ethyl acetate layer. This extraction operation was repeated twice.

この抽出液を芒硝で脱水し,減圧下40’Cで濃縮乾固
し,一夜真空デシケーター中で乾燥して目的物YL−0
1641P−C,の粗粉末を78■を得tムこの粉末は
目的物以外の成分を少量含んでいたので更に純度を高め
るため,Igの水を加えて上記と同様の方法を用いて塩
酸塩の水溶液とした。この水溶液を50tずつ液体クロ
マトグラフィーにかげ目的物YL−01641P C+
のピークを分取した。その時の条件はST−PREP 
ODS−H  (島津テクノリサーチ社製)の2crr
L×25cmカラムを用い,溶離液として002Mリン
酸緩衝液(pH4.2):アセトニトリル:メタノール
(55:15:30)を毎分7mlの割合で溶出し+ 
 254nmのUV検出を用いた。この条件で保持時間
47分34秒に溶出されてきた目的化合物YL−016
41 P−C+の純粋な両分を集めた。分取画分中の該
目的物の確認には上記薄層クロマトグラフィー及び分析
用カラムを用いた液体クロマトグラフイーな用いた。分
析に用いた液体クロマトグラフィーの条件は,分析用S
TR−ODS −H 4.6r+vn X250mm 
 (島津テクノリサーチ社製)カラムを用い,溶離とし
て002Mリン酸緩衝液(pH4.2):アセトニトリ
ル:メタノール(55:15:30)を毎分0.8 m
lの割合で溶出し, 254nmのUV検出を用いた。
This extract was dehydrated with Glauber's salt, concentrated to dryness at 40'C under reduced pressure, and dried overnight in a vacuum desiccator to obtain the target product YL-0.
1641P-C, was obtained as a crude powder of 78 μm. This powder contained a small amount of components other than the target product, so in order to further increase the purity, Ig water was added and hydrochloride was prepared using the same method as above. An aqueous solution of 50 tons of this aqueous solution was passed through liquid chromatography to obtain the target object YL-01641P C+
The peak was fractionated. The conditions at that time are ST-PREP
ODS-H (manufactured by Shimadzu Techno Research) 2 crr
Using a L x 25 cm column, elute 002M phosphate buffer (pH 4.2):acetonitrile:methanol (55:15:30) as the eluent at a rate of 7ml/min.
UV detection at 254 nm was used. Under these conditions, the target compound YL-016 was eluted at a retention time of 47 minutes and 34 seconds.
Both pure fractions of 41 P-C+ were collected. The target substance in the preparative fractions was confirmed using the above-mentioned thin layer chromatography and liquid chromatography using an analytical column. The liquid chromatography conditions used for analysis were
TR-ODS -H 4.6r+vn X250mm
(manufactured by Shimadzu Techno Research Co., Ltd.) column was used for elution with 002M phosphate buffer (pH 4.2):acetonitrile:methanol (55:15:30) at 0.8 m/min.
254 nm UV detection was used.

この様にして分取した画分は減圧下40℃で濃縮し,有
機溶媒を除去した後,この濃縮液と同量の酢酸エチルを
加え,水層のpHが75以上になる様に,炭酸水素ナト
リウム溶液を加えて調整し,良《振盪して目的化合物Y
L O1641P  C+ 物質を酢酸エチル層に抽出
せしめた。この抽出操作は2回繰り返した。次いでこの
酢酸エチルの抽出液を芒硝で脱水し,減圧下40゜Cで
濃縮乾固し,一夜真空デシケーター中で乾燥して目的化
合物YL01641 P−Cの純粋な粉末を27.51
7lgを得た。
The fractions collected in this way were concentrated at 40°C under reduced pressure, and after removing the organic solvent, the same amount of ethyl acetate as the concentrated solution was added, and carbonic acid was added so that the pH of the aqueous layer was 75 or higher. Adjust by adding sodium hydrogen solution and shake well to obtain the target compound Y.
The L O1641P C+ material was extracted into the ethyl acetate layer. This extraction operation was repeated twice. The ethyl acetate extract was then dehydrated with Glauber's salt, concentrated to dryness under reduced pressure at 40°C, and dried overnight in a vacuum desiccator to obtain a pure powder of the target compound YL01641 P-C.
7 lg was obtained.

分取液体クロマトグラフィーで保持時間47分34秒に
溶出された両分から得られた目的物質:この物質は上記
薄層クロマトグラフィーにおけるRf値が028,また
上記分析用力ラムを用いた液体クロマトグラフィーの保
持時間が23分33秒を示す単一物である。
The target substance obtained from both fractions eluted at a retention time of 47 minutes and 34 seconds in preparative liquid chromatography: This substance has an Rf value of 028 in the thin layer chromatography described above, and a liquid chromatography using the analytical ram. It is a single object with a retention time of 23 minutes and 33 seconds.

(1)色および形状:橙黄色結晶性粉末。(1) Color and shape: orange-yellow crystalline powder.

(2)酸性,中性,塩基性の区別:塩基性。(2) Distinction between acidic, neutral, and basic: Basic.

(3)溶解性:メタノール,エタノール,アセトン,酢
酸エチル,ベンゼン,トルエン,クロロホルムには溶け
るが,水には溶けに《<,ヘキサンにはほとんど溶けな
い。
(3) Solubility: Soluble in methanol, ethanol, acetone, ethyl acetate, benzene, toluene, and chloroform, slightly soluble in water, and almost insoluble in hexane.

(4)紫外部吸収スペクトル: YL−01641P−
B,化合物のメタノール中で測定した紫外部吸収スペク
トルは,第11図に示すごとくである。
(4) Ultraviolet absorption spectrum: YL-01641P-
The ultraviolet absorption spectrum of compound B measured in methanol is as shown in FIG.

(5)  マススペクトル(FAB) 774(M+1
)(6)分子式: C39H51 NO+s ,分子量
: 773.830(力 ’H−NMRスペクトル: 
YL−01641P−C,化合物の’H−NMRスペク
トル( 5 0 0MHz, CDC 13)  は第
12図に示すごとくである。
(5) Mass spectrum (FAB) 774 (M+1
) (6) Molecular formula: C39H51 NO+s, molecular weight: 773.830 (force'H-NMR spectrum:
The 'H-NMR spectrum (500 MHz, CDC 13) of the compound YL-01641P-C is as shown in FIG.

上記物埋化学的性状から本物質は下記構造式で示される
YL−01641 P−C,物質である。
Based on the above chemical properties, this substance is YL-01641 P-C, a substance shown by the following structural formula.

(発明の効果) 本発明は,新規且つ有用な微生物を提供すると同時に,
本発明の新規アンスラサイクリン抗腫瘍抗生物質は,各
種腫瘍細胞に対し,細胞障害作用を有している。これら
の作用を以下に示す。
(Effect of the invention) The present invention provides novel and useful microorganisms, and at the same time,
The novel anthracycline antitumor antibiotic of the present invention has cytotoxic effects on various tumor cells. These effects are shown below.

(1)腫瘍細胞を用いる試験管内細胞障害作用試験方法
: ] X 1 05cells/mlに調整したL L 
2 1 0 ”,P388”の各細胞液1mlに,生埋
食塩水で溶解した各濃度の新規アンスラサイクリン系化
合物酒石酸塩の溶液4μtを加え,37℃炭酸ガス培養
器中で3日間培養した後,トリパンプール染色法にまり
生残細胞を計数した。細胞障害活性は,薬剤無添加の細
胞数を対照として各濃度での細胞増殖抑制率を算出し,
グラフ上にプロノ卜して求めた。
(1) In vitro cytotoxicity test method using tumor cells: LL adjusted to 105 cells/ml
210", P388", 4 μt of a solution of tartrate, a new anthracycline compound at each concentration, dissolved in saline was added to 1 ml of each cell suspension, and the cells were cultured for 3 days at 37°C in a carbon dioxide incubator. , and the surviving cells were counted using trypan pool staining. Cytotoxic activity was determined by calculating the cell proliferation inhibition rate at each concentration using the number of cells without drug addition as a control.
It was calculated by plotting it on the graph.

使用したmedium : * RPMI − 1640+ 10%新生子牛血清.
*” RPMI − 1640+  5%牛胎児血清+
5μM2−ヒドロキシエチル ジスルフィド 結   果: (2)  P 3 8 8を用いた動物での抗腫瘍活性
試験法: P388腫瘍細胞5 X 105セルをBDFI/SL
C  5週令オスマウスに腹腔内接種し,接種翌日より
YL−01641P A+物質の酒石酸塩を腹腔内投与
で5日間連投した効果は対照群の中間生存日数に対する
YL−01641 P−A,物質投与群の中間生存日数
の比より延命率を算出して求めた。
Medium used: *RPMI-1640+10% newborn calf serum.
*”RPMI-1640+ 5% fetal bovine serum+
5μM 2-Hydroxyethyl disulfide Results: (2) Antitumor activity test method in animals using P388: BDFI/SL of P388 tumor cells 5 x 105 cells.
C. The effect of intraperitoneal inoculation of YL-01641P A+ substance tartrate for 5 days after intraperitoneal inoculation into 5-week-old male mice was as follows. The survival rate was calculated from the ratio of median survival days.

結果: 本発明化合物を実際に投与する場合には,一般的に注射
剤等で非経口的に投与する方法が用いられるが,本発明
の化合物を,医学製剤の分野で用いられる通常の製薬学
的に許容できる個体又は液体状の担体と混合し,散剤,
顆粒剤,錠剤またはシロップ等の剤型に製剤して,経口
的に投与することもできる。
Results: When actually administering the compound of the present invention, parenteral administration using an injection or the like is generally used. It can be mixed with a physically acceptable solid or liquid carrier to form a powder,
It can also be formulated into granules, tablets, syrups, etc. and administered orally.

一般的な投与法としては,動物の場合,腹腔内注射,静
脈又は動脈への血管内注射及び局所投与等の注射剤とし
て投与され,その投与量は動物試験の結果及び種々状況
を勘案して総投与量が一定量を越えない範囲で,連続的
又は間欠的に投与することが出来る。しかし,その投与
量は投与方法,患者,又は被処理動物の状況,例えば年
令,体重,性別,感受性,食餌,投与時間,投与方法,
併用する薬剤,患者又はその病気の程度に応じて適宜に
変えて投与し得ることはもちろんである。本発明化合物
の通常の投与量は,抗腫瘍剤として用いる場合,1日1
回当り0.30]g//kg乃至1 5 mg/kg 
ノ範囲であることが出来る。一定の条件の下における適
量と投与回数は,上記の指針を基として専門医の適量決
定試験によって決定されなければいけない。
The general administration method for animals is intraperitoneal injection, intravascular injection into a vein or artery, and local administration, and the dosage is determined based on the results of animal studies and various circumstances. It can be administered continuously or intermittently so that the total dose does not exceed a certain amount. However, the dosage depends on the method of administration, the circumstances of the patient or treated animal, such as age, body weight, sex, sensitivity, diet, time of administration, method of administration, etc.
Of course, the administration can be changed as appropriate depending on the concomitant drugs, the patient, or the severity of the disease. When used as an antitumor agent, the usual dosage of the compound of the present invention is 1 dose per day.
0.30] g//kg to 15 mg/kg per serving
It can be in the range of The appropriate dose and frequency of administration under certain conditions must be determined by a specialist in an appropriate dose determination test based on the above guidelines.

これらの投与方法は,経口投与においても同様に考慮さ
れる。
These administration methods are also considered for oral administration.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は, YL−01641P−A,化合物の紫外外
吸収スペクトノレを示す。 第2図は,  YL−01641P−AI化合物の’H
−NMRスペクトルを示す。 第3図は, YL−01641P−A,化合物の13C
−NMRスペクトルを示す。 第4図は,  YL−01641P−へ化合物の紫外部
吸収スペクトルを示す。 第5図は, YL−01641P−A2化合物のIH−
NMRスペクトルを示す。 第6図は, YL−01641P−B2化合物の紫外部
吸収スペクトルを示す。 第7図は, YL−01641P−B2化合物の’H−
NMRスペクトルを示す。 第8図は, YL−01641P B+化合物の紫外部
吸収スペクトルを示す。 第9図は, YL−01641P−B,化合物の’H−
NMRスペクトルを示す。 第10図は, YL−01641P B+化合物の’3
C−NMRスペクトルを示す。 第11図は.  YL−01641P−C,化合物の紫
外部吸収スベクトノレを示す。 第12図は, YL−01641P−C,化合物の’H
−NMRスペクトルを示す。 (ノ 0
FIG. 1 shows the ultraviolet absorption spectrum of the compound YL-01641P-A. Figure 2 shows the 'H of YL-01641P-AI compound.
- Shows the NMR spectrum. Figure 3 shows the 13C of YL-01641P-A, compound
- Shows the NMR spectrum. Figure 4 shows the ultraviolet absorption spectrum of the compound YL-01641P-. Figure 5 shows the IH-
The NMR spectrum is shown. FIG. 6 shows the ultraviolet absorption spectrum of YL-01641P-B2 compound. Figure 7 shows the 'H-
The NMR spectrum is shown. FIG. 8 shows the ultraviolet absorption spectrum of YL-01641P B+ compound. Figure 9 shows YL-01641P-B, 'H-
The NMR spectrum is shown. Figure 10 shows the '3 of YL-01641P B+ compound.
A C-NMR spectrum is shown. Figure 11 is. YL-01641P-C, shows the ultraviolet absorption spectrum of the compound. Figure 12 shows the 'H of YL-01641P-C, compound
- Shows the NMR spectrum. (No 0

Claims (7)

【特許請求の範囲】[Claims] (1)下記平面化学構造式で表わされるアンスラサイク
リン系物質又はその酸付加塩。 ▲数式、化学式、表等があります▼ (式中、R^1は水素原子又は水酸基を、R^2は水素
原子又は低級アルキル基を、R^3は水素原子又は低級
アルカノイル基を意味する。)
(1) Anthracycline substances or acid addition salts thereof represented by the planar chemical structural formula below. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R^1 means a hydrogen atom or a hydroxyl group, R^2 means a hydrogen atom or a lower alkyl group, and R^3 means a hydrogen atom or a lower alkanoyl group. )
(2)R^1が水素原子又は水酸基、R^2が水素原子
又はメチル基、R^3が水素原子又はアセチル基である
請求項(1)に記載のアンスラサイクリン系物質又はそ
の酸付加塩。
(2) The anthracycline substance or its acid addition salt according to claim (1), wherein R^1 is a hydrogen atom or a hydroxyl group, R^2 is a hydrogen atom or a methyl group, and R^3 is a hydrogen atom or an acetyl group. .
(3)R^1が水酸基、R^2がメチル基及びR^3が
アセチル基である請求項(2)記載のアンスラサイクリ
ン系物質またはその酸付加塩。
(3) The anthracycline substance or its acid addition salt according to claim (2), wherein R^1 is a hydroxyl group, R^2 is a methyl group, and R^3 is an acetyl group.
(4)ノカルディア属に属し、請求項(2)記載のアン
スラサイクリン系物質を生産する能力を有する微生物を
培地に培養し、培養物中に該アンスラサイクリン系物質
を生産し、蓄積させ、該培養物から生成蓄積したアンス
ラサイクリン系物質を採取することを特徴とするアンス
ラサイクリン系物質の製造法。
(4) Cultivating a microorganism belonging to the genus Nocardia and having the ability to produce the anthracycline substance according to claim (2) in a medium, producing and accumulating the anthracycline substance in the culture; A method for producing an anthracycline substance, which comprises collecting an anthracycline substance produced and accumulated from a culture.
(5)ノカルディア属に属する菌株が、ノカルディアエ
ス・ピーYL−01641P(微工研条寄第2737号
)である請求項(4)記載の製造法。
(5) The production method according to claim (4), wherein the strain belonging to the genus Nocardia is Nocardia S.P. YL-01641P (Feikoken Joyori No. 2737).
(6)ノカルディア属に属し、請求項(1)に記載のア
ンスラサイクリン系物質を産生し得る微生物。
(6) A microorganism belonging to the genus Nocardia and capable of producing the anthracycline substance according to claim (1).
(7)ノカルディア属に属する菌株がノカルディアエス
・ピーYL−01641P(微工研条寄第2737号)
である請求項(6)に記載の微生物。
(7) The strain belonging to the genus Nocardia is Nocardia S.P. YL-01641P (Feikoken Joyori No. 2737)
The microorganism according to claim (6).
JP4651190A 1989-03-15 1990-02-27 Anthracycline substance, preparation thereof and bacterium producing the same Pending JPH03216198A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4651190A JPH03216198A (en) 1989-03-15 1990-02-27 Anthracycline substance, preparation thereof and bacterium producing the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1-64667 1989-03-15
JP6466789 1989-03-15
JP1-285462 1989-11-01
JP4651190A JPH03216198A (en) 1989-03-15 1990-02-27 Anthracycline substance, preparation thereof and bacterium producing the same

Publications (1)

Publication Number Publication Date
JPH03216198A true JPH03216198A (en) 1991-09-24

Family

ID=26386603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4651190A Pending JPH03216198A (en) 1989-03-15 1990-02-27 Anthracycline substance, preparation thereof and bacterium producing the same

Country Status (1)

Country Link
JP (1) JPH03216198A (en)

Similar Documents

Publication Publication Date Title
EP0335386A1 (en) KS-506 compounds and process for the production thereof
JPH0686682A (en) Production of 4&#39;,7,8-trihydroxyisoflavone
EP0239774B1 (en) New biosynthetic anthracyclines related to daunorubicin
JPH03216198A (en) Anthracycline substance, preparation thereof and bacterium producing the same
JPS6212227B2 (en)
JPH07278041A (en) Antitumor substance BE-24811 and method for producing the same
US4296101A (en) Antibiotic kristenin
JPH0578322A (en) New antibiotic sf2738 substance, its production and carcinostatic agent
JP3106012B2 (en) Method for producing oxazoline derivative
JP2786219B2 (en) Y-09194L-B substance and method for producing the substance
EP0178902B1 (en) Novel vasodilator compounds, process for the preparation thereof and pharmaceutical compositions containing same
JPH0625095B2 (en) Antibiotic SF-2415 substance and its production method
JP2594085B2 (en) SF2575, a new antitumor antibiotic, and method for producing the same
JPH0259596A (en) Novel substance, utilization and production thereof
JP3109923B2 (en) Manufacturing method of new trehazolin derivatives
JP2718002B2 (en) New strain Streptomyces lavendofolia DKRS and method for producing aclacinomycin A, B, Y and aglycone using the same
JP3026862B2 (en) New anthracycline compounds
EP0311054A2 (en) Anthracycline Antibiotics
JPH06316595A (en) Cyclic peptide compound
JPH05207884A (en) New macrolide antibiotic substances sf2748b, sf2748c1, sf2748d and sf2748e and their production
JPS63157992A (en) Antibiotic substance n-hydroxydihydroabikoviromycin
JP2000026468A (en) Human immunodeficiency virus growth inhibitor and method for producing the same
JPH0517484A (en) Antitumor substance BE-22179
JPH0359911B2 (en)
JPH03279379A (en) New compound indanonaphthol a and b